DexCom Long Term Debt 2010-2023 | DXCM

DexCom long term debt from 2010 to 2023. Long term debt can be defined as the sum of all long term debt fields.
  • DexCom long term debt for the quarter ending December 31, 2023 was $2.434B, a 103.24% increase year-over-year.
  • DexCom long term debt for 2023 was $2.434B, a 103.24% increase from 2022.
  • DexCom long term debt for 2022 was $1.198B, a 39.57% decline from 2021.
  • DexCom long term debt for 2021 was $1.982B, a 18.87% increase from 2020.
DexCom Annual Long Term Debt
(Millions of US $)
2023 $2,434
2022 $1,198
2021 $1,982
2020 $1,667
2019 $1,060
2018 $1,010
2017 $328
2016 $
2015 $
2014 $2
2013 $5
2012 $7
2011 $
2010 $
2009 $46
DexCom Quarterly Long Term Debt
(Millions of US $)
2023-12-31 $2,434
2023-09-30 $2,432
2023-06-30 $2,431
2023-03-31 $1,199
2022-12-31 $1,198
2022-09-30 $1,969
2022-06-30 $1,967
2022-03-31 $1,966
2021-12-31 $1,982
2021-09-30 $1,704
2021-06-30 $1,711
2021-03-31 $1,689
2020-12-31 $1,667
2020-09-30 $1,646
2020-06-30 $1,659
2020-03-31 $1,072
2019-12-31 $1,060
2019-09-30 $1,047
2019-06-30 $1,035
2019-03-31 $1,022
2018-12-31 $1,010
2018-09-30 $339
2018-06-30 $335
2018-03-31 $331
2017-12-31 $328
2017-09-30 $324
2017-06-30 $321
2017-03-31
2016-12-31
2016-09-30
2016-06-30
2016-03-31
2015-12-31
2015-09-30 $0
2015-06-30 $1
2015-03-31 $2
2014-12-31 $2
2014-09-30 $3
2014-06-30 $4
2014-03-31 $4
2013-12-31 $5
2013-09-30 $5
2013-06-30 $6
2013-03-31 $6
2012-12-31 $7
2012-09-30
2012-06-30
2012-03-31
2011-12-31
2011-09-30
2011-06-30
2011-03-31
2010-12-31
2010-09-30 $1
2010-06-30 $3
2010-03-31 $5
2009-12-31 $46
2009-09-30 $45
2009-06-30 $2
2009-03-31 $43
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $53.067B $3.622B
DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients. A key element of DexCom's monitoring system technology is the continuous measure of patient's blood glucose level and transmission of that information to a small cell phone-sized receiver in real time. The company's monitoring systems aim to provide real-time continuous blood glucose values, trend data and alerts to assist patients in managing their blood glucose levels.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $219.329B 26.67
Intuitive Surgical (ISRG) United States $133.752B 80.57
Edwards Lifesciences (EW) United States $52.819B 34.96
IQVIA Holdings (IQV) United States $43.310B 25.69
IDEXX Laboratories (IDXX) United States $41.012B 49.04
Alcon (ALC) Switzerland $39.823B 29.37
STERIS (STE) Ireland $20.355B 24.09
Waters (WAT) United States $18.582B 26.66
Hologic (HOLX) United States $18.119B 20.00
SONOVA HOLDING (SONVY) Switzerland $16.651B 0.00
Fresenius Medical Care AG KGaA (FMS) Germany $12.605B 15.56
ShockWave Medical (SWAV) United States $12.286B 84.89
Sysmex ADR (SSMXY) Japan $10.120B 31.74
Teleflex (TFX) United States $9.944B 15.61
Penumbra (PEN) United States $7.961B 98.42
Masimo (MASI) United States $7.246B 40.64
Globus Medical (GMED) United States $6.941B 22.00
Glaukos (GKOS) United States $5.074B 0.00
Integer Holdings (ITGR) United States $3.950B 25.25
LivaNova (LIVN) United Kingdom $2.969B 19.58
TransMedics (TMDX) United States $2.964B 0.00
PROCEPT BioRobotics (PRCT) United States $2.763B 0.00
Elekta AB (EKTAY) Sweden $2.704B 18.55
Nihon Kohden (NHNKY) Japan $2.379B 20.12
Integra LifeSciences Holdings (IART) United States $2.309B 9.48
Tandem Diabetes Care (TNDM) United States $2.258B 0.00
Inari Medical (NARI) United States $2.151B 371.10
RxSight (RXST) United States $2.031B 0.00
Alphatec Holdings (ATEC) United States $1.784B 0.00
Veracyte (VCYT) United States $1.489B 0.00
OPKO Health (OPK) United States $0.871B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.867B 16.03
Artivion (AORT) United States $0.856B 98.95
Paragon 28 (FNA) United States $0.833B 0.00
OrthoPediatrics (KIDS) United States $0.729B 0.00
Silk Road Medical (SILK) United States $0.692B 0.00
Treace Medical Concepts (TMCI) United States $0.671B 0.00
SiBone (SIBN) United States $0.627B 0.00
Mesa Laboratories (MLAB) United States $0.575B 19.53
IRadimed (IRMD) United States $0.531B 30.81
ORTHOFIX MEDICAL INC (OFIX) United States $0.495B 0.00
Nevro (NVRO) United States $0.469B 0.00
NeuroPace (NPCE) United States $0.402B 0.00
Pacific Biosciences Of California (PACB) United States $0.394B 0.00
Pulse Biosciences (PLSE) United States $0.379B 0.00
Tactile Systems Technology (TCMD) United States $0.346B 11.66
CVRx (CVRX) United States $0.309B 0.00
AxoGen (AXGN) United States $0.305B 0.00
Sight Sciences (SGHT) United States $0.279B 0.00
EDAP TMS S.A (EDAP) France $0.263B 0.00
AngioDynamics (ANGO) United States $0.242B 0.00
Accuray (ARAY) United States $0.220B 0.00
Semler Scientific (SMLR) United States $0.190B 10.26
Atossa Genetics (ATOS) United States $0.187B 0.00
908 Devices (MASS) United States $0.183B 0.00
Alpha Tau Medical (DRTS) Israel $0.174B 0.00
Inogen (INGN) United States $0.162B 0.00
ClearPoint Neuro (CLPT) United States $0.149B 0.00
Delcath Systems (DCTH) United States $0.142B 0.00
Neuronetics (STIM) United States $0.116B 0.00
Yubo Biotech (YBGJ) China $0.112B 0.00
Envoy Medical (COCH) United States $0.101B 0.00
KORU Medical Systems (KRMD) United States $0.098B 0.00
Spectral Diagnostics (EDTXF) Canada $0.086B 0.00
EnVVeno Medical (NVNO) United States $0.073B 0.00
Monogram Orthopaedics (MGRM) United States $0.072B 0.00
SEP Acquisition (SEPA) United States $0.059B 0.00
Hyperfine (HYPR) United States $0.059B 0.00
Autonomix Medical (AMIX) United States $0.056B 0.00
Sensus Healthcare (SRTS) United States $0.056B 113.33
Vasomedical (VASO) United States $0.054B 9.73
Vicarious Surgical (RBOT) United States $0.050B 0.00
InspireMD (NSPR) Israel $0.046B 0.00
DarioHealth (DRIO) United States $0.043B 0.00
Aspira Women's Health (AWH) United States $0.042B 0.00
ReWalk Robotics (LFWD) Israel $0.042B 0.00
Rapid Micro Biosystems (RPID) United States $0.039B 0.00
LENSAR (LNSR) United States $0.036B 0.00
Pixie Dust Technologies (PXDT) Japan $0.036B 0.00
Lucid Diagnostics (LUCD) United States $0.035B 0.00
Precision Optics (POCI) United States $0.034B 0.00
Spectral AI (MDAI) United States $0.032B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.023B 0.00
Ekso Bionics Holdings (EKSO) United States $0.021B 0.00
Accelerate Diagnostics (AXDX) United States $0.021B 0.00
QT Imaging Holdings (QTI) United States $0.019B 0.00
PAVmed (PAVM) United States $0.017B 0.00
Biosig Technologies (BSGM) United States $0.017B 0.00
T2 Biosystems (TTOO) United States $0.015B 0.00
NexGel (NXGL) United States $0.014B 0.00
Check-Cap (CHEK) Israel $0.013B 0.00
Microbot Medical (MBOT) United States $0.013B 0.00
Avinger (AVGR) United States $0.006B 0.00
Venus Concept (VERO) Canada $0.005B 0.00
Helius Medical Technologies (HSDT) United States $0.004B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Tenon Medical (TNON) United States $0.003B 0.00
Dynatronics (DYNT) United States $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Nuwellis (NUWE) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.001B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00